Inventor

TIMMER JOHN C

US39 patents

⚠️ This page may combine multiple inventors who share the name “TIMMER JOHN C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TIMMER JOHN C

INHIBRX INC

Non-immunogenic single domain antibodies

Multispecific polypeptide constructs having constrained CD3 binding and methods of using the same

Serpin fusion polypeptides and methods of use thereof

Serpin fusion polypeptides and methods of use thereof

Multivalent and multispecific 41BB-binding fusion proteins

Multivalent and multispecific DR5-binding fusion proteins

Multispecific GITR-binding fusion proteins and methods of use thereof

CD33-binding polypeptides and uses thereof

Multivalent and multispecific OX40-binding fusion proteins

Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells

Serpin fusion polypeptides and methods of use thereof

Serpin fusion polypeptides and methods of use thereof

Multivalent and multispecific DR5-binding fusion proteins and methods of treating neoplasms

CD123-binding polypeptides and uses thereof

PDL1-binding proteins

CD123-binding polypeptides and uses thereof

OX40-binding polypeptides and uses thereof

PD-1 single domain antibodies and therapeutic compositions thereof

OX40-binding polypeptides and uses thereof

PD-1 single domain antibodies and therapeutic compositions thereof

Type III secretion system targeting molecules

Type III secretion system targeting molecules

Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids

INHIBRX BIOSCIENCES INC

CLEC12a binding polypeptides and uses thereof

Multivalent and multispecific OX40-binding fusion proteins

Multivalent and multispecific 41BB-binding proteins

OX40-binding polypeptides and uses thereof

PD-1 single domain antibodies and therapeutic compositions thereof

CD33-binding polypeptides and uses thereof

5T4 single domain antibodies and therapeutic compositions thereof

Multispecific polypeptide constructs having constrained CD3 binding and related methods and uses

Multispecific polypeptide constructs containing a constrained CD3 binding domain and a receptor binding region and methods of using the same

DLL3 single domain antibodies and therapeutic compositions thereof

CD28 single domain antibodies and multivalent and multispecific constructs thereof

INHIBRX LP

Serpin fusion polypeptides and methods of use thereof

Serpin fusion polypeptides and methods of use thereof

REGENERON PHARMA

CD33 targeted immunotherapies

CLL-1 targeted immunotherapies

INHIBRX LLC

WAP domain fusion polypeptides and methods of use thereof